
	For the thirteen weeks ended				For the twenty-six weeks ended
	June 28, 2026		June 29, 2025		June 28, 2026		June 29, 2025
Numerator:
Net income (loss)	$	(2,430)	$	10,863	$	4,826	$	13,680
Denominator:
Weighted average common shares outstanding - basic	120,284,587		119,162,895		120,049,592		119,005,954
Dilutive effect of potential common shares from RSUs	—		346,941		910,509		462,500
Dilutive effect of potential common shares from PSUs	—		280,789		188,658		208,230
Weighted average common shares outstanding - diluted	120,284,587		119,790,625		121,148,759		119,676,684
Earnings per share:
Basic	$	(0.02)	$	0.09	$	0.04	$	0.11
Diluted	$	(0.02)	$	0.09	$	0.04	$	0.11

The following outstanding shares of Common Stock equivalents were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive. Warrants to purchase shares of Common Stock having an exercise price greater than the average share market price are excluded from the calculation of diluted earnings per share.


	For the thirteen weeks ended		For the twenty-six weeks ended
	June 28, 2026	June 29, 2025	June 28, 2026	June 29, 2025
Anti-dilutive shares excluded from calculation of diluted EPS:
Warrants	14,633,311	14,633,311	14,633,311	14,633,311
Stock options	355,715	437,268	355,715	437,268
Restricted stock units	1,129,254	2,058,769	218,745	2,058,769
Performance stock units	2,293,111	2,264,503	2,104,453	2,264,503
Unvested earn-out shares	1,093,750	1,093,750	1,093,750	1,093,750
Total anti-dilutive shares	19,505,141	20,487,601	18,405,974	20,487,601